Security record · archived quarter
TARS
Tarsus Pharmaceuticals, Inc. · Healthcare · Biotechnology
14Tracked holders
0Δ holders
10.63MShares held
$430.62MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -3.6% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 102 | +3 | 26.51M | $1.67B | +7 | −3 |
| Q1 2026 | 101 | +5 | 27.05M | $1.90B | +10 | −6 |
| Q4 2025 | 97 | 0 | 27.39M | $2.24B | +2 | −1 |
| Q3 2025 | 16 | 0 | 11.66M | $693.15M | +1 | −2 |
| Q2 2025 | 14 | 0 | 10.63M | $430.62M | — | — |
| Q1 2025 | 11 | +2 | 4.92M | $252.88M | +2 | — |
| Q4 2024 | 9 | 0 | 3.55M | $196.55M | — | — |
| Q3 2024 | 8 | 0 | 2.33M | $76.49M | — | — |
| Q2 2024 | 8 | — | 2.46M | $66.86M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 3.79M | — | $153.62M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 2.30M | — | $93.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 2.30M | — | $93.07M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 2.30M | — | $93.07M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passive) | 2.30M | — | $93.07M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passive) | 2.30M | — | $93.07M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passive) | 980.87K | +7.7% | $39.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passive) | 934.42K | +8.0% | $37.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passive) | 934.42K | +8.0% | $37.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 723.18K | +76.1% | $29.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 723.18K | +76.1% | $29.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 543.00K | +6.5% | $22.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Norges Bank ✦ (passive) | 471.35K | +20.5% | $19.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 383.90K | -11.4% | $15.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 383.90K | -11.4% | $15.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 229.25K | -76.9% | $9.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 123.64K | +6.5% | $5.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 123.64K | +6.5% | $5.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 123.64K | +6.5% | $5.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 123.64K | +6.5% | $5.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 123.64K | +6.5% | $5.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Millennium Management ✦ | 58.14K | -76.5% | $2.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 53.57K | +230.2% | $2.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 53.57K | +230.2% | $2.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 53.57K | +230.2% | $2.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 19.85K | — | $804,132 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 19.85K | — | $804,132 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 19.02K | -35.0% | $770,703 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 252 holders, 45.11M shares, $3.08B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API